Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020;31(7):844-860, https://doi.org/10.1016/j.annonc.2020.03.304
Article CAS PubMed Google Scholar
Niederle B, Pape UF, Costa F, et al. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology 2016;103(2):125-38, https://doi.org/10.1159/000443170
Article CAS PubMed Google Scholar
DelBaugh RM, Kerr DA, Dominguez-Konicki L, et al. Metastatic Neuroendocrine Neoplasms to the Pancreas: Two Unusual Cases and a Review of the Literature. Int J Surg Pathol 2023;10668969231185067, https://doi.org/10.1177/10668969231185067
Spadaccini M, Conti Bellocchi MC, Mangiavillano B, et al. Secondary Tumors of the Pancreas: A Multicenter Analysis of Clinicopathological and Endosonographic Features. J Clin Med 2023;12(8), https://doi.org/10.3390/jcm12082829
Su H-A, Chen C-J, Yen H-H. Unusual cause of intestinal obstruction: Breast cancer with solitary ileal metastasis diagnosed after enteroscopy. Advances in Digestive Medicine: 2017.
Abbo O, Pinnagoda K, Micol LA, et al. Osteosarcoma metastasis causing ileo-ileal intussusception. World J Surg Oncol 2013;11(1):188, https://doi.org/10.1186/1477-7819-11-188
Article PubMed PubMed Central Google Scholar
Liu W, Zhou W, Qi WL, et al. Gastrointestinal hemorrhage due to ileal metastasis from primary lung cancer. World J Gastroenterol 2015;21(11):3435-40, https://doi.org/10.3748/wjg.v21.i11.3435
Article PubMed PubMed Central Google Scholar
Kos-Kudła B, Castaño JP, Denecke T, et al. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol 2023;35(12):e13343, https://doi.org/10.1111/jne.13343
Article CAS PubMed Google Scholar
Mapelli P, Fallanca F, Franchini A, et al. Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 2020;47(11):2713-2714, https://doi.org/10.1007/s00259-020-04719-9
Article CAS PubMed Google Scholar
Tsunenari T, Aosasa S, Ogata S, et al. Synchronous neuroendocrine tumors in both the pancreas and ileum: A case report. Int J Surg Case Rep 2016;22(47–50, https://doi.org/10.1016/j.ijscr.2016.03.028
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76(2):182-188, https://doi.org/10.1111/his.13975
Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol 2022;33(1):115-154, https://doi.org/10.1007/s12022-022-09708-2
Article CAS PubMed Google Scholar
Uccella S, La Rosa S, Volante M, et al. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms. Endocr Pathol 2018;29(2):150-168, https://doi.org/10.1007/s12022-018-9522-y
Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol 2020;96(8–33, https://doi.org/10.1016/j.humpath.2019.12.002
Luchini C, Pelosi G, Scarpa A, et al. Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach. Pathologica 2021;113(1):28-38, https://doi.org/10.32074/1591-951X-231
Article PubMed PubMed Central Google Scholar
Mohindroo C, Baydogan S, Agarwal P, Wright RD, Prakash LR, Mork ME, Klein AP, Laheru DA, Maxwell JE, Katz MHG, Dasari A, Kim MP, He J, McAllister F, De Jesus-Acosta A. Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer Prev Res (Phila). 2024 Apr 25. https://doi.org/10.1158/1940-6207.CAPR-23-0483. Epub ahead of print. PMID: 38662083.
Uccella S. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That? Endocr Pathol. 2024 Mar 12. https://doi.org/10.1007/s12022-024-09807-2. Epub ahead of print. PMID: 38470548.
Singh S, Law C. Abstract #128 ENET: Multidisciplinary reference centers: the need for combined expertise in the diagnosis and treatment of neuroendocrine tumors. . 2010. Available from: https://www.enets.org/abstract/multidisciplinary-reference-centers-the-need-for-combined-expertise-in-the-diagnosis-and-treatment-of-neuroendocrine-tumors.html.
Davar J, Connolly HM, Caplin ME, et al. Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement. J Am Coll Cardiol 2017;69(10):1288-1304, https://doi.org/10.1016/j.jacc.2016.12.030
Oberg K, Krenning E, Sundin A, et al. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect 2016;5(5):174-87, https://doi.org/10.1530/EC-16-0043
Article CAS PubMed PubMed Central Google Scholar
Uccella S, Sessa F, La Rosa S. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas. Turk Patoloji Derg 2015;31 Suppl 1(113–27, https://doi.org/10.5146/tjpath.2015.01319
La Rosa S, Franzi F, Albarello L, Schmitt A, Bernasconi B, Tibiletti MG, Finzi G, Placidi C, Perren A, Capella C. Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors. Pancreas. 2011 Aug;40(6):883-95. https://doi.org/10.1097/MPA.0b013e31822041a9. PMID: 21705949.
Article CAS PubMed Google Scholar
Perren A, Couvelard A, Scoazec JY, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification. Neuroendocrinology 2017;105(3):196-200, https://doi.org/10.1159/000457956
留言 (0)